HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Mascaux, C. Articles by Sculier, J-P. Search for Related Content PubMed PubMed Citation Articles by Mascaux, C. Articles by Sculier, J-P.

COX-2 expression during early lung squamous cell carcinoma oncogenesis

¹ Dept of Intensive Care and Thoracic Oncology, ² Dept of Pathology, Institut Jules Bordet, and ³ Dept of Pneumology, CHU Saint-Pierre, Brussels, Belgium.

CORRESPONDENCE: C. Mascaux, Institut Jules Bordet, rue Héger-Bordet, 1, B-1000 Brussels, Belgium. Fax: 32 25343756. E-mail: celine.mascaux@bordet.be

Keywords: Carcinogenesis, chemoprevention, cyclooxygenase-2, lung cancer, pre-malignant lesion, tumour markers

Received: January 5, 2005
Accepted May 3, 2005

Cyclooxygenase (COX)-2 is implicated in the oncogenesis of many cancers, and COX-2 inhibitors are effective in preventing the development of tumours, such as in colon cancer. Its expression is increased in nonsmall cell lung cancer and is associated with poor prognosis. The present study assessed COX-2 expression in normal bronchial epithelium, as well as in all the putative precursors of squamous cell carcinomas.

COX-2 expression was studied by immunohistochemistry in 106 biopsies collected during autofluorescence bronchoscopy in consecutive patients at high-risk for lung cancer.

All biopsies corresponding to normal epithelium or low-grade lesions (lesions up to moderate dysplasia) did not show increased COX-2 expression. Lesions were positive for COX-2 in eight out of 14 severe dysplasia patients, eight out of 14 in situ carcinomas and five out of eight invasive carcinomas. A strong statistically significant difference in COX-2 expression was found between normal epithelium or low-grade lesions and high-grade lesions (severe dysplasia or worse). The positive and negative predictive values of COX-2 expression for high-grade lesion were 100% and 82.35%, respectively.

In conclusion, bronchial precursors of squamous cell carcinoma showed increased cyclooxygenase-2 expression and were segregated into low- versus high-grade with a high positive predictive value. Thus, cyclooxygenase-2 appears as a potential early marker of squamous cell carcinoma.

This article has been cited by other articles:

				C. Mascaux, F. Bex, B. Martin, A. Burny, A. Haller, M. Paesmans, K. Willard-Gallo, V. Ninane, and J-P. Sculier The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma Eur. Respir. J., September 1, 2008; 32(3): 678 - 686. [Abstract] [Full Text] [PDF]

				P Ulivi, L Mercatali, W Zoli, D Dell'Amore, V Poletti, G L Casoni, E Scarpi, E Flamini, D Amadori, and R Silvestrini Serum free DNA and COX-2 mRNA expression in peripheral blood for lung cancer detection Thorax, September 1, 2008; 63(9): 843 - 844. [Full Text] [PDF]